PTGX
Protagenic Therapeutics issues $250,000 promissory note
The company issued a loan to Patness LLC, with repayment partially contingent on an equity financing of at least $1 million, which could impact liquidity and flexibility.
PTGX news
Latest 3 stories · newest Nov 6, 2026
PTGX
PTGX
Protagonist Therapeutics adopts 2026 Equity Incentive Plan
Protagonist Therapeutics' board adopted and stockholders approved a new 2026 Equity Incentive Plan on June 17, 2026, succeeding the prior 2016 plan. The new plan expands share reserves and provides equity awards to employees, directors, and consultants to retain talent and align incentives with comp…
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same PTGX feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/PTGX/newsSTART FREE